BPC-157 successor with extended PK
Gut barrier restoration
recovery agonist pocket: ortho · ▲ 0 · seed bank · 2026-05-02 12:35
🎁 Free tier: 3 design runs / 24h per IP. Each run
produces 4 candidates with full Compounding Lab Spec Sheets — no
signup needed.
Have an API key?
Desired effect
Restore intestinal epithelial barrier integrity and reduce permeability; favor multi-target peptide acting on GH/IGF-1 + nitric-oxide + dopaminergic pathways (BPC-157 mechanism class).
Mechanism rationale
This recovery-lane idea targets the mechanism described in the effect statement. Curated from the platform's 22-effect taxonomy.
Novelty basis
Underexplored in the academic + commercial literature, or addressed only by small-molecule programs. Peptide modality offers selectivity advantages.
Strategic value
Lane wedge: recovery. Buyer archetypes include longevity biotechs, metabolic pharma, and performance/wellness brands depending on indication. Run Phase 4 and judge the public-stats output.
Design parameters
| Primary target | (matcher will resolve) |
|---|---|
| Secondary targets | — |
| Binding mode | agonist |
| Pocket mode | ortho |
| Modality hint | 10-15 aa cyclic peptide via head-to-tail or i,i+4 disulfide |